Tizanidine Hydrochloride

盐酸替扎尼定

Report date: 2025/07/04 15:31:46
NME

Base Information

Drug NameTizanidine Hydrochloride
Drug Alias Name替扎尼定TizanidinumTizanidineTizanidinaZanaflex +[16] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors alpha-2 agonists
TargetsAdrenergic receptors alpha-2
Therapy Area/IndicationsOpioid-Related DisordersNeck PainChronic Pain +[11] 
Global Approved IndicationsMultiple SclerosisMuscle Spasticity
Approved Indications in ChinaMultiple SclerosisMuscle Spasticity
Original Approved Country/TerritoryJapan
Original Approved Date1996/03/05
Country/TerritoryCanadaUnited StatesIsrael +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSawai Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSawai Pharmaceutical Co LtdLegacy Pharma USA IncStanford University +[6] 
Inactive CompaniesElan PharmaceuticalsAcorda TherapeuticsSun Pharma Advanced Research Company Ltd +[5] 
Active IndicationsOpioid-Related DisordersNeck PainChronic Pain +[8] 
Inactive IndicationsSpinal Cord InjuriesBrain Injuries, TraumaticMyalgia

Other Information

ATC CodeM03BX02
Related LinksWikipediaDrugBankKEGG